BD0392245
Lisinopril , 98% , 76547-98-3
CAS NO.：76547-98-3
Empirical Formula: C21H31N3O5
Molecular Weight: 405.49
MDL number: MFCD00214086
EINECS: 278-488-1
| Pack Size | Price | Stock | Quantity |
| 100mg | RMB203.20 | In Stock |
|
| 250mg | RMB308.00 | In Stock |
|
| 1g | RMB728.80 | In Stock |
|
| 5g | RMB1460.00 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 162-165 °C |
| Boiling point: | 666.4±55.0 °C(Predicted) |
| Density | 1.251±0.06 g/cm3(Predicted) |
| storage temp. | Keep in dark place,Inert atmosphere,2-8°C |
| solubility | H2O: ≥10 mg/mL |
| form | solid |
| pka | 2.18±0.10(Predicted) |
| color | white |
| BCS Class | 3 |
Description and Uses
Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor (IC50 = 1.2 nM). It reduces the formation of endothelin-1 and increases nitric oxide (NO) in human vascular endothelial cells when used at a concentration of 0.1 nM. Lisinopril inhibits the pressor response to angiotensin I in anesthetized rats and dogs (ID50s = 2.3 and 6.5 μg/kg, respectively).
Labeled Lisinopril, intended for use as an internal standard for the quantification fo Lisinopril by GC- or LC-mass spectrometry.
Safety
| Symbol(GHS) |  GHS08 |
| Signal word | Warning |
| Hazard statements | H361-H373 |
| Precautionary statements | P201-P202-P260-P280-P308+P313-P405-P501 |
| Safety Statements | 22-24/25 |
| WGK Germany | 3 |
| RTECS | TW3589990 |
